Virax Biolabs Group Limited (VRAX) NASDAQ

1.09

+0.0075(+0.69%)

Updated at May 15 09:55AM

Currency In USD

Valuation

Market Cap1.47M
Enterprise Value-1.89M
P/E Ratio-0.51
PEG Ratio-0.02
Price/Sales Ratio55.51
Price/Book Ratio0.39
Enterprise/Revenue-23.23
Enterprise/EBITDA0.3

Fiscal Year

Fiscal YearMarch 31, 2024
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-77.53
Operating Margin-78.58

Management Effectiveness

Return On Assets-0.7
Return On Equity-0.94

Income Statement

Revenue156,419
Revenue/Share0.03
Gross Profit50,590
EBITDA-6.61M
Net Income-6.73M
Diluted EPS-3.36

Balance Sheet

Total Cash7.38M
Total Cash/Share2.38
Total Debt603,202
Total Debt/Equity0.07
Current Ratio11.58
Book Value Per Share2.72

Price History

52-Week Change38.22
52-Week High9
52-Week Low0.75
Moving Average 50 Days1.13
Moving Average 200 Days1.92

Statistics

Average Volume191,939
Shares Outstanding4.34M
% Held by Institutions3.14

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateDecember 18, 2023